hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301619PMID 11850720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax

  2000cited by this paper
• Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

  2000cited by this paper
• Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.

  2000cited by this paper
• Adenoviral Bak overexpression mediates caspase-dependent tumor killing.

  2000cited by this paper
• A Novel Telomerase-Specific Gene Therapy: Gene Transfer of Caspase-8 Utilizing the Human Telomerase Catalytic Subunit Gene Promoter

  2000cited by this paper
• Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines.

  2000cited by this paper
• NF-κB Regulates Transcription of the Mouse Telomerase Catalytic Subunit*

  2000cited by this paper
• NF-kappa B regulates transcription of the mouse telomerase catalytic subunit.

  2000cited by this paper
• Adenovirus-Mediated Transfer of Caspase-8 Augments Cell Death in Gliomas: Implication for Gene Therapy

  2000cited by this paper
• Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter.

  2000cited by this paper
• Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.

  1999cited by this paper
• Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

  1999cited by this paper
• Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation

  1999cited by this paper
• Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.

  1999cited by this paper
• Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.

  1999cited by this paper
• Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

  1999cited by this paper
• Telomerase activity in candidate stem cells from fetal liver and adult bone marrow.

  1998cited by this paper
• Apoptosis by Retrovirus- and Adenovirus-Mediated Gene Transfer of Fas Ligand to Glioma Cells: Implications for Gene Therapy

  1998cited by this paper
• Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia

  1998cited by this paper
• Myc activates telomerase.

  1998cited by this paper
• A survey of telomerase activity in human cancer.

  1997cited by this paper
• Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

  1997cited by this paper
• Adenovirus Mediated Alpha Interferon (IFN‐α) Gene Transfer into CD34+ Cells and CML Mononuclear Cells

  1997cited by this paper
• Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.

  1996cited by this paper
• Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.

  1996cited by this paper
• Telomerase activity in hematopoietic cells is associated with self-renewal potential.

  1996cited by this paper
• Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors.

  1996cited by this paper
• Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.

  1994cited by this paper
• In vitro and in vivo targeting of gene expression to melanoma cells.

  1993cited by this paper

• Multilevel Targeting of Canine Adenovirus Type 2 (CAV2) to Expand Oncolytic Virotherapy in Canine Tumors

  2020cites this paper
• Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors

  2020cites this paper
• Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases

  2019cites this paper
• Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells

  2019cites this paper
• Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer

  2017cites this paper
• Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.

  2016cites this paper
• Cancer‐specific promoters for expression‐targeted gene therapy: ran, brms1 and mcm5

  2016cites this paper
• Telomere and Telomerase in Cancer

  2016cites this paper
• Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.

  2015cites this paper
• Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.

  2014cites this paper
• A Suicide-inducing Vector Carrying the Oct-4 Promoter for Eradication of the AGS Cancer Cell Line

  2012cites this paper
• Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma

  2012cites this paper
• Exploiting the Intron-splicing Mechanism of Insect Cells to Produce Viral Vectors Harboring Toxic Genes for Suicide Gene Therapy

  2012cites this paper
• Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell

  2011cites this paper
• Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b

  2011cites this paper
• Adenovirus-Based Gene Therapy for Cancer

  2011cites this paper
• Gene therapy with tumor-specific promoter mediated suicide gene plus IL-12 gene enhanced tumor inhibition and prolonged host survival in a murine model of Lewis lung carcinoma

  2011cites this paper
• Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter

  2011cites this paper
• A Novel Oncolytic Adenovirus Expressing Escherichia coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors

  2010cites this paper
• Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax

  2010cites this paper
• Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus

  2010cites this paper
• Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer

  2010cites this paper
• Determining the role of endothelial progenitor cells in post-natal neovascularization

  2010cites this paper
• Tumor-Specific, Hypoxia-Regulated, WW Domain-Containing Oxidoreductase-Expressing Adenovirus Inhibits Human Non-Small Cell Lung Cancer Growth In Vivo

  2010cites this paper
• Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo

  2010cites this paper
• Transgene expression of α tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity

  2009cites this paper
• Telomeres and telomerase: Biological and clinical importance in dogs.

  2008cites this paper
• Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice

  2008cites this paper
• Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

  2008cites this paper
• Anti-tumor and Radio-sensitizing Properties of Ad-IU2, A Prostate-specific Replication-competent Adenovirus Armed with TRAIL

  2008cites this paper
• Heat induced reporter and therapeutic gene expression in cancer gene therapy.

  2008cites this paper
• Targeting telomerase for cancer therapeutics

  2008cites this paper
• Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers

  2008cites this paper
• The Role of Enhanced Radiosensitivity and Tumor-specific Suicide Gene Vector in Genetherapy of Nasopharyngeal Carcinoma

  2007cites this paper
• Gene Therapy for Advanced Prostate Cancer

  2007cites this paper
• TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection.

  2007cites this paper
• Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.

  2007cites this paper
• Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth

  2007cites this paper
• Adenovector-Mediated Cancer Gene Therapy

  2007cites this paper
• Evaluation of telomerase control elements and radiation-inducible Waf1 promoter for the enhancement of targeted radiotherapy in neuroblastoma cells

  2007cites this paper
• Carboxypeptidase G2-based gene-directed enzyme–prodrug therapy: a new weapon in the GDEPT armoury

  2007cites this paper
• Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas

  2007cites this paper
• Harnessing telomerase in cancer therapeutics.

  2007cites this paper
• Telomeres and telomerase as targets for anticancer drug development.

  2006cites this paper
• Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

  2006cites this paper
• Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.

  2006cites this paper
• Telomerase therapeutics for cancer: challenges and new directions

  2006cites this paper
• hTERT/re-caspase-3 system induce apoptosis in hTERT-positive

  2006cites this paper
• A survivin‐mediated oncolytic adenovirus induces non‐apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo

  2006cites this paper
• In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

  2006cites this paper
• The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells

  2006cites this paper
• Targeting Gene-Virotherapy of Cancer and its prosperity

  2006cites this paper
• Vector Targeting in Gene Therapy

  2006cites this paper
• Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model.

  2006cites this paper
• Targeted gene therapy for breast cancer with truncated Bid

  2006cites this paper
• The importance of the telomere and telomerase system in hematological malignancies

  2005cites this paper
• MDM2 negatively regulates the human telomerase RNA gene promoter

  2005cites this paper
• P-Glycoprotein-Independent Apoptosis Induction by a Novel Synthetic Compound, MMPT [5-[(4-Methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone]

  2005cites this paper
• Transcriptionally targeted adenovirus vectors.

  2005cites this paper
• Gene Therapy Targeting Receptor-Mediated Cell Death to Cancers

  2005cites this paper
• Combination Bcl-2 Antisense and Radiation Therapy for Nasopharyngeal Cancer

  2005cites this paper
• Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma.

  2005cites this paper
• Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma

  2005cites this paper
• Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.

  2005cites this paper
• Etude de modalités multithérapeutiques et diagnostiques appliquées au cancer du pancréas

  2005cites this paper
• Replacement and suicide gene therapy for targeted treatment of lung cancer.

  2005cites this paper
• Telomerase: A potential molecular marker and therapeutic target for cancer

  2004cites this paper
• Noninvasive Imaging of the Transcriptional Activities of Human Telomerase Promoter Fragments in Mice

  2004cites this paper
• New Trends in Biomedical Aging Research

  2004cites this paper
• Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the TRAIL Gene from the Human Telomerase Reverse Transcriptase Promoter

  2004cites this paper
• Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

  2004cites this paper
• Effective Gene-Viral Therapy for Telomerase-Positive Cancers by Selective Replicative-Competent Adenovirus Combining with Endostatin Gene

  2004cites this paper
• Telomerase as a new target for the treatment of hormone-refractory prostate cancer.

  2004cites this paper
• Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells

  2004cites this paper
• Telomere maintenance in clinical medicine.

  2004cites this paper
• Drug Insight: cancer cell immortality—telomerase as a target for novel cancer gene therapies

  2004cites this paper
• Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States.

  2004cites this paper
• Xenograftic tumor models in mice for cancer research , a technical review

  2004cites this paper
• Telomerase inhibitors: a new option for chemotherapy.

  2003cites this paper
• A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.

  2003cites this paper
• Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.

  2003cites this paper
• System for Simultaneous Tissue-Specific and Disease-Specific Regulation of Therapeutic Gene Expression

  2003cites this paper
• Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase

  2003cites this paper
• Tumor Suppressing Gene Therapy

  2003cites this paper
• Enhancing adenovirus‐mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone

  2003cites this paper
• Telomerase Promoter-Driven Cancer Cell Suicide

  2003cites this paper
• N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers

  2003cites this paper
• Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model

  2003cites this paper
• Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.

  2003cites this paper
• Telomerase-dependent oncolytic adenovirus for cancer treatment

  2003cites this paper
• Transcriptional Targeting in Cancer Gene Therapy

  2003cites this paper
• Telomerase: a target for cancer therapeutics.

  2002cites this paper
• Human Telomerase and Its Regulation

  2002cites this paper
• A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo

  2002cites this paper
• Anti-Aging Medicine LiteratureWatch

  2002cites this paper
• Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft

  2002cites this paper